Adelaide researchers have identified a promising new biomarker and treatment target for ovarian cancer that could markedly ...

Veteran journalist Christiane Amanpour, who shared her ovarian cancer diagnosis in 2021, revealed she's battling the disease ...

Victorian researchers are leading the best in the world to find better ways to diagnose and treat a rare type of ovarian ...

Adelaide researchers have identified a promising new biomarker and treatment target for ovarian cancer that could markedly ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to the antibody-drug conjugate JSKN003 for the ...

Christiane Amanpour has been diagnosed with cancer again. The 67-year-old chief international anchor for CNN shared the news ...

Stage 2 ovarian cancer means the cancer is present in one or both ovaries and has spread to other pelvic tissues, such as the ...

Cancer immunotherapy, which uses drugs that stimulate the body's immune cells to attack tumors, is a promising approach to ...

Nanoparticles carrying IL-12 are non-toxic, elicit strong systemic antitumor immunity, and sensitize ovarian tumors to ICI therapy, a new study shows.

The annual event will be held Saturday, Nov. 8 from 8 a.m. - 12 p.m. at Cranes Roost Park in Altamonte Springs.

Research reveals IL-12 nanoparticles paired with checkpoint inhibitors can eradicate ovarian tumors, showcasing potential for ...

Scientists in Australia have identified a promising new biomarker and treatment target for ovarian cancer that could markedly improve the outlook for women diagnosed with this aggressive disease.